MyOme Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MyOme Inc. - overview
Established
2017
Location
Palo Alto, CA, US
Primary Industry
Biotechnology
About
Founded in 2017 and based in California, US, MyOme Inc. is a biotech company that helps families and individuals to understand and identify genes and diseases that are inherited from their family. The company is certified under the Clinical Laboratory Improvement Amendments (CLIA) and is led by CEO Premal Shah, PhD. Founders of the company include Matthew Rabinowitz, co-founder of Natera, Kate Im, and Akash Kumar.
In October 2019, MyOme Inc. raised Series A funding from new investors HOF Capital and Norwest Venture Partners. And in June 2022, MyOme raised USD 32 million in Series B funding led by new investors HealthCare Ventures, with participation from other new investors Foresite Capital, Founders Fund, Natera Inc. , SBI Investment, and Sequoia Capital as well as unspecified investors.
The Series B funding values MyOme Inc. at USD 132 million post-money. The company offers a complete analysis of disease risk through clinical-grade whole genome sequencing. MyOme analyzes the DNA data and provides proactive health and pharmacogenomics reports on-demand to answer clinically relevant questions throughout a patient’s life related to risk for cardiac, diabetes, autoimmune, cancer risk, and other conditions, response to certain medications, single gene and polygenic analysis to assess the risk of multifactorial diseases, rare diseases, and pharmacogenomics.
Current Investors
Norwest Venture Partners, HOF Capital, HealthCare Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.myome.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
MyOme Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.